New York Times. The Food and Drug Administration has added new warnings to the blockbuster cholesterol drug Zocor which is taken by an estimated 2.1 million Americans, cautioning doctors that the highest dose of the drug can cause muscle damage and potentially lethal kidney damage. (Wilson, 6/8) Blog post

CVS Caremark.  A new study by researchers at Harvard University, Brigham and Women's Hospital and CVS Caremark finds that 45 percent of people who provide care and support to relatives say they are more likely to be non-adherent to their personal medication regimen. More than 65 million Americans describe themselves as caregivers, a number expected to grow as the population ages. (5/25) Press release  

Agency for Healthcare Research and Quality.  States are seeing improvements in health care quality, but disparities still exist according to the 2010 State Snapshots, recently released by AHRQ. Report  

Associated Press. Moody's Investor's Service maintained a positive view of the largest U.S. pharmacy benefits managers Tuesday, saying it has the highest opinion of CVS Caremark Corp. (6/7) Full story

Forbes.  CVS Caremark, the largest pharmacy services provider in the US, got a much needed boost to its pharmacy services unit by winning a $3 billion pharmacy contract that provides mail order and specialty pharmacy benefit coverage to federal employees. (Team, 6/6) Full story

Bloomberg. Pfizer, the world's largest drug company, will join with Harvard University affiliated hospitals in a $100 million project that will bring together university and industry researchers to speed drug discovery. (Langreth & Lauerman, 6/8) Full story   

ABC News. The White House is pushing back against a report by consulting firm McKinsey & Company that states 30 percent of employers will "definitely or probably" stop offering health insurance coverage to employees after 2014. (Khan, 6/8) Full story  

June Co-op Feature